Purpose: Isolated vestibular-lateral semicircular canal dysplasia (LSCCD) is one of the most common anomalies of the inner ear. However, endolymphatic size in LSCCD is unknown. We measured the size of the endolymph in the vestibule of patients with LSCCD and compared it with that measured in patients without LSCCD.
Introduction
There are many kinds of inner ear malformations, and various classification systems for these malformations have been proposed. 1, 2 Isolated vestibular-lateral semicircular canal dysplasia (LSCCD) is one of the most common inner ear anomalies. 3 In cases of complete LSCCD, the vestibular and lateral semicircular canals form a single fluid-filled cavity. In contrast, isolated LSCCD shows no cochlear abnormalities and no dilation of the vestibular aqueduct. Thus, the relationships between LSCCD and hearing loss or LSCCD and vertigo are controversial. 4, 5 A determination of LSCCD is made when the area of the central bony island (CBI) measured by magnetic resonance (MR) or computed tomography (CT) is less than 7 mm 2 . 6 LSCCD can occur as a sporadic or syndromic malformation.
Recently, evaluation of endolymphatic hydrops using magnetic resonance (MR) imaging has been performed clinically in patients with suspected Ménière's disease. [7] [8] [9] A specific size criterion for the diagnosis of endolymphatic hydrops has been proposed for the inner ear without significant morphological anomaly. 10 According to this criterion, endolymph occupying more than half of the total vestibular space is defined as significant endolymphatic hydrops. Histopathological reports of ears with syndromic LSCCD have described dilated vestibular endolymph. 11, 12 However, the size of the endolymph space in sporadic isolated LSCCD is unknown. Therefore, we do not know if the previously proposed diagnostic size criterion, which was established based on data from ears without morphological anomalies, is applicable to patients with LSCCD.
The purpose of this study was to measure the size of the endolymphatic space in the vestibules of patients with LSCCD (aplasia or hypoplasia of the LSCC) and compare that with measurements from patients without LSCCD.
Materials and Methods

Patients
From our hospital's database of radiology reports for the period from April 2010 to March 2014, we extracted 1102 MR studies performed for the evaluation of endolymphatic hydrops. Experienced otorhinolaryngologists made the differential diagnosis of Ménière's disease based on the guidelines of the American Academy of Ophthalmology and Otolaryngology-Head and Neck Surgery (AAO-HNS). Endolymphatic hydrops was evaluated in all patients with suspected endolymphatic hydrops, except those patients with contraindications for MR or gadolinium-based contrast material (GBCM) and those who refused MR examination.
Among the 1102 MR examinations, we found 11 cases with LSCCD (aplasia or hypoplasia of the LSCC), four of these with bilateral abnormalities. Seven ears demonstrated aplasia and 8 ears, hypoplasia of the LSCC. In our clinical department, we diagnose LSCCD if the maximum area of the central bony island (CBI, central bony part of the LSCC) as measured on an axial MR cisternographic (MRC) image is less than 7 mm 2 . 4, 6 We consider the absence of the CBI to represent aplasia of the LSCC, and if the area of the CBI is between 0 and 7 mm 2 , it is considered to be hypoplasia of the LSCC.
For comparison, we randomly selected from the same time period 26 ears of 13 patients with no inner ear abnormalities other than endolymphatic hydrops as controls. When selecting the control patients, we first excluded patients whose reports described morphological abnormalities, such as inner ear anomaly or incidentally found vestibular schwannoma, and then excluded patients with reports describing increased permeability of the blood-labyrinthine barrier likely due to labyrinthitis and otosclerosis. Table details the patients with LSCCD and those in the control group.
Two patients with LSCCD had received intratympanic (IT) administration of GBCM. All other patients, those with LSCCD and controls, received intravenous (IV) administration of a single dose of GBCM.
MR imaging
All MR imaging was performed using a 3-tesla unit (Verio, Siemens, Erlangen, Germany) with a 32-channel array head coil.
Those patients who received GBCM intravenously underwent MR scanning 4 hours after single-dose (SD) (0.2 mL/kg or 0.1 mmol/kg body weight) administration of gadolinium-diethylenetriamine pentaacetic acid-bis (methylamide) (gadodiamide, Gd-DTPA-BMA; Omniscan, Daiichi-Sankyo Co. Ltd., Tokyo, Japan) to evaluate the degree of endolymphatic hydrops. The estimated glomerular filtration rate (eGFR) of each of these patients exceeded 60 mL/min/1.73 m 2 . According to the clinical protocol of our hospital for the evaluation of endolymphatic hydrops, patients underwent heavily T 2 -weighted (hT 2 W) MRC for anatomical reference of total lymph fluid and hT 2 W 3-dimensional (3D) fluid-attenuated inversion recovery (FLAIR) with a 2250-msec inversion time (TI) (positive perilymph image, PPI) 4 hours after receiving IV-SD-GBCM.
Detailed scan parameters for MRC were: hT 2 W MRC images using variable flip angle 3D turbo spin echo technique (SPACE, sampling perfection with application-optimized contrasts using different flip angle evolutions); repetition time (TR), 4400 ms; echo time (TE), 544 ms; frequency-selective fat-suppression pre-pulse; initial refocusing 180°flip angle rapidly decreased to constant 120°fl ip angle for the refocusing echo train; echo-train length, 173 with restore magnetization pulse (fast recovery pulse); matrix size, 322 © 384; 96 axial Parameters for the acquisition of the PPI were similar to those of MRC except: TR, 9000 ms; TI, 2250 ms, without restore magnetization pulse; 4 excitations; and scan time of 14 min.
On the scanner console, we subtracted the MRC multiplied by 0.04 from the PPI to generate HY-DROPS2 images (HYbriD of Reversed image Of MR cisternography and positive Perilymph Signal by heavily T 2 -weighted 3D-FLAIR) 13 
For those who underwent IT administration of GBCM, 3D-real inversion recovery (IR) images were obtained as well as MRC and PPI (hT 2 W-3D-FLAIR) as described above. The parameters for 3D-real IR were: TR, 6000 ms; effective TE, 181 ms; TI, 1650 ms; 180°constant flip angle for the conventional turbo-spin-echo refocusing echo train; echo train length, 27; matrix size, 384 © 384; 30 axial slices of 0.8-mm thickness; FOV, 160 © 160 mm; GRAPPA acceleration factor, 2; voxel size, 0.4 © 0.4 © 0.8 mm; NEX, one; scan time, 14 min 32 s; readout bandwidth, 213 Hz/pixel; echo spacing, 13 ms; and reconstruction mode "real." Patients received a dose of 8-fold diluted gadopentetate dimeglumine (Magnevist, Bayer Co. Ltd., Osaka, Japan) in one ear 24 hours prior to MR scanning according to the procedure previously detailed for IT injection. 9 Our medical ethics committee approved the use of the IT method for GBCM administration, and all patients gave written informed consent. The committee also approved this retrospective analysis of data using the IT and IV methods and waived informed consent.
Image analysis
We used MR cisternography to measure the total area of vestibular lymph fluid (TLA), defined as the maximum area covering the LSCC and vestibule minus the area of the CBI. The area of endolymph (ELA) was defined as the area of low signal in the vestibule in hT 2 W-3D-FLAIR 14 or HYDROPS2 13 images for patients who received GBCM by IV administration and in hT 2 W-3D-FLAIR or 3D-real IR images 15 for those who received contrast by the IT method. When measuring the ELA, we used hT 2 W-3D-FLAIR images if perilymph surrounded the ELA and HYDROPS2 or 3D-real IR images if the ELA was large and not completely surrounded by the perilymph. The ELA was measured manually by circumscribing the region of interest on a PACS viewer at the slice where TLA measurement had been performed. Cochlear endolymphatic hydrops is graded subjectively according to proposed criteria as none, mild, or significant. 10 We extracted patient age, average hearing level (at 500, 1000, and 2000 Hz) by pure-tone audiometry, and presence or absence of rotating vertigo attacks from electronic medical records. A neuroradiologist with 26 years of experience performed image evaluation and measurements. Endolymphatic ratio (%EL) was defined as: %EL = ELA/TLA © 100. Figure 1 shows an example of area measurement.
Statistical analysis
We tested differences in mean %EL among the control, hypoplastic, and aplastic LSCC groups by one-way analysis of variance (ANOVA), linear trend analysis, and Scheffé post hoc analysis; performed intergroup comparisons between control and hypoplastic or aplastic LSCC using the Fisher exact test for categorical variables and a t test for numeric variables; and evaluated the correlation between the area of the CBI and %EL using Pearson's correlation coefficient. We adopted 5% as the significance level for all statistical tests. 
Results
Representative MRC and HYDROPS2 images of control (Fig. 2) , LSCC hypoplasia (Fig. 3) , and LSCC aplasia (Fig. 4) are shown as examples. Figure 5 shows the distribution of %EL for normal, hypoplastic, and aplastic LSCC. The mean « standard deviation of %EL was 76.7 « 12.8% in the aplasia group, 50.0 « 7.0% in the hypoplasia group, and 27.8 « 11.1% in the control group. There was a statistically significant difference in the mean %EL among the 3 types of LSCC (P < 0.001) and a strong linear trend in these means (P < 0.001; Fig. 5 ). Further, pairwise comparisons among them demonstrated a statistically significant difference between each group pairing in %EL (P < 0.001). As shown in Fig. 6 , a relatively strong linear correlation was observed between the area of the CBI and the %EL; Pearson's correlation coefficient (r) was ¹0.767 (P < 0.001). There were no significant differences in intergroup comparisons for age, average hearing level, degree of cochlear EH, or presence of vertigo attacks. 
Discussion
LSCCD is the most frequently found vestibular inner ear malformation 16 and can be detected by endolymphatic hydrops imaging as described in the present study. The LSCC is the last of the 3 semicircular canals to be formed during the fetal period, so it is particularly vulnerable and frequently malformed. 1 In this study, we found LSCCD in 11 of 1102 cases (approximately 1%). The relationship between LSCCD and hearing loss or vertigo is still unclear. 4, 5 In cases without symptoms, the likelihood of detecting LSCCD by diagnostic imaging is very small. As a result, the precise frequency of isolated LSCCD remains unknown.
Enlargement of the endolymphatic space in LSCCD has not been reported in isolated LSCCD, but it has been reported in histopathological study of syndromic LSCCD. A case report of trisomy 22 with dysplasia of the LSCC described enlarged utricular endolymph but normal saccular endolymph. 12 During fetal development, the membranous labyrinth develops first, followed by develop- Fig. 5 . This figure shows the distribution of the ratio of endolymphatic area to total lymphatic area (%EL) for the patients with normal, hypoplastic, and aplastic lateral semicircular canal. Open circles show the distribution of the estimated area ratio for patients with normal, hypoplastic, and aplastic lateral semicircular canal. Open squares show the mean; error bars indicate standard deviation. There is a statistically significant difference in the mean %EL among the 3 types of LSCC (P < 0.001) and a strong linear trend in these means (P < 0.001). ment of the bony labyrinth. Development of the CBI might be key in the morphogenesis of a normal-shaped membranous labyrinth in the vestibule and LSCC.
Morphological diagnosis of endolymphatic hydrops by MR imaging requires diagnostic criteria, but none are currently established for patients with inner ear anomalies. In the present study, we showed that vestibular endolymph is larger in cases with LSCCD than those without. Thus, the current criteria established based on ears without inner ear malformation 10 might not be applicable to ears with LSCCD. To establish criteria for ears with malformations, further collection and analysis of cases with malformation are necessary.
One limitation of this study is that we used 2 different methods of GBCM administration in the ears with LSCCD, although we used only the IV method for ears of the control group. Two patients with LSCCD underwent the IT method. No study has directly compared %EL values in the same patients between IV and IT administration methods. Both methods utilize the barrier protecting the endolymphatic space from outside. We believe that the difference in %EL values between the 2 methods may be small, but future studies comparing them are warranted.
Our retrospective study is also limited because all subjects underwent MR imaging for the evaluation of endolymphatic hydrops. Selection bias cannot be ruled out for both the LSCCD group and control group, although there was no significant difference in the degree of cochlear endolymphatic hydrops, age, hearing level, or presence of vertigo among 3 groups.
Conclusions
The mean %EL was larger in the groups with LSCC aplasia or hypoplasia than the control group. Thus, the current diagnostic cut-off value for significant vestibular endolymphatic hydrops (>50%) might not be appropriate for patients with LSCCD. 
